OpenAI to acquire Orchestra Bio to bring AI-powered operations to life sciences R&D
AIOpenAI is acquiring Orchestra Bio, a company it says will bring AI-powered operations to life sciences research and development. The stated goal is to help biopharma teams accelerate drug development and advance new treatments.
Loading source posts…
Source details
OpenAI News · openai.comPublished · added here
Original title: OpenAI acquires Orchestra Bio